Form 8-K - Current report:
SEC Accession No. 0000950170-24-127768
Filing Date
2024-11-18
Accepted
2024-11-18 07:02:24
Documents
62
Period of Report
2024-11-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lrmr-20241118.htm   iXBRL 8-K 40829
2 EX-99.1 lrmr-ex99_1.htm EX-99.1 56855
3 GRAPHIC lrmr-ex99_1s1.jpg GRAPHIC 194225
4 GRAPHIC lrmr-ex99_1s2.jpg GRAPHIC 688560
5 GRAPHIC lrmr-ex99_1s3.jpg GRAPHIC 515232
6 GRAPHIC lrmr-ex99_1s4.jpg GRAPHIC 405506
7 GRAPHIC lrmr-ex99_1s5.jpg GRAPHIC 378376
8 GRAPHIC lrmr-ex99_1s6.jpg GRAPHIC 337680
9 GRAPHIC lrmr-ex99_1s7.jpg GRAPHIC 338124
10 GRAPHIC lrmr-ex99_1s8.jpg GRAPHIC 360482
11 GRAPHIC lrmr-ex99_1s9.jpg GRAPHIC 441542
12 GRAPHIC lrmr-ex99_1s10.jpg GRAPHIC 348359
13 GRAPHIC lrmr-ex99_1s11.jpg GRAPHIC 343072
14 GRAPHIC lrmr-ex99_1s12.jpg GRAPHIC 410730
15 GRAPHIC lrmr-ex99_1s13.jpg GRAPHIC 380853
16 GRAPHIC lrmr-ex99_1s14.jpg GRAPHIC 186194
17 GRAPHIC lrmr-ex99_1s15.jpg GRAPHIC 475465
18 GRAPHIC lrmr-ex99_1s16.jpg GRAPHIC 391667
19 GRAPHIC lrmr-ex99_1s17.jpg GRAPHIC 477310
20 GRAPHIC lrmr-ex99_1s18.jpg GRAPHIC 417056
21 GRAPHIC lrmr-ex99_1s19.jpg GRAPHIC 470301
22 GRAPHIC lrmr-ex99_1s20.jpg GRAPHIC 422303
23 GRAPHIC lrmr-ex99_1s21.jpg GRAPHIC 357472
24 GRAPHIC lrmr-ex99_1s22.jpg GRAPHIC 336580
25 GRAPHIC lrmr-ex99_1s23.jpg GRAPHIC 452777
26 GRAPHIC lrmr-ex99_1s24.jpg GRAPHIC 515368
27 GRAPHIC lrmr-ex99_1s25.jpg GRAPHIC 191534
28 GRAPHIC lrmr-ex99_1s26.jpg GRAPHIC 179821
29 GRAPHIC lrmr-ex99_1s27.jpg GRAPHIC 336407
30 GRAPHIC lrmr-ex99_1s28.jpg GRAPHIC 148383
31 GRAPHIC lrmr-ex99_1s29.jpg GRAPHIC 405035
32 GRAPHIC lrmr-ex99_1s30.jpg GRAPHIC 319744
33 GRAPHIC lrmr-ex99_1s31.jpg GRAPHIC 285098
34 GRAPHIC lrmr-ex99_1s32.jpg GRAPHIC 398104
35 GRAPHIC lrmr-ex99_1s33.jpg GRAPHIC 347341
36 GRAPHIC lrmr-ex99_1s34.jpg GRAPHIC 326123
37 GRAPHIC lrmr-ex99_1s35.jpg GRAPHIC 133675
38 GRAPHIC lrmr-ex99_1s36.jpg GRAPHIC 357399
39 GRAPHIC lrmr-ex99_1s37.jpg GRAPHIC 401947
40 GRAPHIC lrmr-ex99_1s38.jpg GRAPHIC 317811
41 GRAPHIC lrmr-ex99_1s39.jpg GRAPHIC 322441
42 GRAPHIC lrmr-ex99_1s40.jpg GRAPHIC 326037
43 GRAPHIC lrmr-ex99_1s41.jpg GRAPHIC 224656
44 GRAPHIC lrmr-ex99_1s42.jpg GRAPHIC 161006
45 GRAPHIC lrmr-ex99_1s43.jpg GRAPHIC 266075
46 GRAPHIC lrmr-ex99_1s44.jpg GRAPHIC 316268
47 GRAPHIC lrmr-ex99_1s45.jpg GRAPHIC 342047
48 GRAPHIC lrmr-ex99_1s46.jpg GRAPHIC 344738
49 GRAPHIC lrmr-ex99_1s47.jpg GRAPHIC 139362
50 GRAPHIC lrmr-ex99_1s48.jpg GRAPHIC 386422
51 GRAPHIC lrmr-ex99_1s49.jpg GRAPHIC 136701
52 GRAPHIC lrmr-ex99_1s50.jpg GRAPHIC 446187
  Complete submission text file 0000950170-24-127768.txt   23917621

Data Files

Seq Description Document Type Size
53 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lrmr-20241118.xsd EX-101.SCH 23893
64 EXTRACTED XBRL INSTANCE DOCUMENT lrmr-20241118_htm.xml XML 4533
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 241469743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)